XML 44 R35.htm IDEA: XBRL DOCUMENT v3.25.3
Stock-Based Compensation and Employee Benefits (Tables)
12 Months Ended
Dec. 31, 2024
Stock-Based Compensation and Employee Benefits  
Summary of Option Activity

Options

Weighted-

Average

Aggregate

Weighted-

Remaining

Intrinsic

    

Number of

Average

Contractual Terms

Value

Options

Exercise Price

(Years)

(in thousands)

Outstanding at December 31, 2023

23,659,240

$

13.31

Granted - at fair value

 

10,513,500

$

2.28

 

Exercised

 

(174,651)

$

1.67

 

Forfeited/Canceled

 

(5,292,979)

$

9.20

 

Outstanding at December 31, 2024

28,705,110

$

10.10

6.4

$

889

Exercisable at December 31, 2024

 

17,010,902

$

14.37

4.6

$

Schedule of options outstanding and exercisable

Information on the options outstanding and exercisable as of December 31, 2024 is summarized by range of exercise prices as follows:

    

Options Outstanding

Options Exercisable

Weighted-

    

Average

Weighted-

Weighted-

Remaining

Average

Average

Number

Contractual Terms

Exercise

Number

Exercise

Range of Exercise Prices

Outstanding

(Years)

Price

Exercisable

Price

$

0.77

-

$

2.41

 

6,361,791

9.5

$

1.74

473,666

$

2.35

$

2.59

-

$

5.44

6,000,496

8.3

$

3.86

2,069,330

$

4.33

$

5.86

-

$

12.37

5,603,496

5.3

$

10.28

4,386,405

$

10.54

$

12.44

-

$

17.06

4,601,126

5.3

$

14.64

3,992,175

$

14.59

$

17.17

-

$

26.58

4,691,013

3.8

$

18.90

4,642,138

$

18.91

$

26.62

-

$

36.85

1,447,188

0.5

$

29.06

1,447,188

$

29.06

 

28,705,110

6.4

$

10.10

17,010,902

$

14.37

Schedule of additional information on options

Year Ended December 31,

(in thousands, except weighted-average grant-date fair value per share)

2024

2023

Total intrinsic value of options exercised

 

$

110

$

425

Total grant date fair value of options vested

 

$

22,778

$

30,467

Weighted-average grant date fair value per share of options granted

 

$

1.49

$

4.19

Summary of RSU Activity, under 2014 Plan

RSUs Outstanding

Weighted-Average

    

Number of

    

Grant Date Fair 

RSUs

Value

Balances at December 31, 2023

 

1,726,729

$

11.93

RSUs granted

 

1,976,750

$

2.23

RSUs vested

 

(2,793,626)

$

5.41

RSUs canceled

 

(141,616)

$

11.50

Balances at December 31, 2024

 

768,237

$

10.79

Year Ended December 31,

(in thousands, except weighted-average grant-date fair value per share)

2024

2023

Total grant date fair value of RSUs vested

 

$

15,101

$

18,381

Total grant date fair value of RSUs granted

 

$

4,408

$

11,386

Weighted-average grant-date fair value per share of RSUs granted

 

$

2.23

$

8.93

Schedule of Stock-Based Compensation Expense

Year Ended December 31, 

(in thousands)

    

2024

    

2023

Cost of goods sold (1)

$

1,070

$

632

Research and development

 

8,643

 

14,596

Selling, general and administrative

 

18,089

 

27,882

Stock-based compensation subtotal

27,802

43,110

Less: Stock-based compensation from discontinued operations

(1,682)

(4,005)

Total stock-based compensation expense from continuing operations

$

26,120

$

39,105

 

  

 

  

Total stock-based compensation expense capitalized into inventory

$

1,407

$

1,062

(1)Stock-based compensation capitalized into inventory is recognized as cost of goods sold when the related product is sold.
Schedule of Weighted Average Assumptions for Black-Scholes Option-Pricing Model Used in Determining Fair Value of Awards

Year Ended December 31, 

    

2024

    

2023

    

Expected term (years)

 

 

  

 

Stock options

 

5.7

 

6.0

 

ESPP

 

0.5

 

0.5

 

Expected volatility

 

 

 

Stock options

 

67

%  

64

%  

ESPP

 

88

%  

105

%  

Risk-free interest rate

 

 

 

Stock options

 

3.97

%  

3.92

%  

ESPP

 

4.94

%  

5.35

%  

Expected dividend yield

 

  

 

  

 

Stock options

 

%  

%  

ESPP

 

%  

%